| Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) M Duvic, R Talpur, X Ni, C Zhang, P Hazarika, C Kelly, JH Chiao, JF Reilly, ... Blood 109 (1), 31-39, 2007 | 1289 | 2007 |
| Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes L Wang, X Ni, KR Covington, BY Yang, J Shiu, X Zhang, L Xi, Q Meng, ... Nature genetics 47 (12), 1426-1434, 2015 | 318 | 2015 |
| Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action C Zhang, V Richon, X Ni, R Talpur, M Duvic Journal of Investigative Dermatology 125 (5), 1045-1052, 2005 | 277 | 2005 |
| Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action C Zhang, P Hazarika, X Ni, DA Weidner, M Duvic Clinical cancer research 8 (5), 1234-1240, 2002 | 238 | 2002 |
| Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sezary … X Ni, JL Jorgensen, M Goswami, P Challagundla, WK Decker, YH Kim, ... Clinical Cancer Research 21 (2), 274-285, 2015 | 147 | 2015 |
| Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape? X Ni, P Hazarika, C Zhang, R Talpur, M Duvic Clinical cancer research 7 (9), 2682-2692, 2001 | 84 | 2001 |
| Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study N Apisarnthanarax, R Talpur, S Ward, X Ni, HW Kim, M Duvic Journal of the American Academy of Dermatology 50 (4), 600-607, 2004 | 81 | 2004 |
| Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application M Duvic, X Ni, R Talpur, K Herne, C Schulz, D Sui, S Ward, A Joseph, ... Journal of investigative dermatology 121 (4), 902-909, 2003 | 75 | 2003 |
| Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas X Ni, C Zhang, R Talpur, M Duvic Journal of investigative dermatology 124 (4), 741-750, 2005 | 65 | 2005 |
| Increased Twist expression in advanced stage of mycosis fungoides and Sezary syndrome M Goswami, M Duvic, A Dougherty, X Ni Journal of cutaneous pathology 39 (5), 500-507, 2012 | 37 | 2012 |
| Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab X Ni, T Langridge, M Duvic Oncoimmunology 4 (7), e1011524, 2015 | 36 | 2015 |
| The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sezary syndrome cells C Zhang, X Ni, M Konopleva, M Andreeff, M Duvic Journal of Investigative Dermatology 123 (2), 380-387, 2004 | 32 | 2004 |
| Essential role of DNA methyltransferase 1–mediated transcription of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors HY Min, SC Lee, JK Woo, HJ Jung, KH Park, HM Jeong, SY Hyun, J Cho, ... Clinical Cancer Research 23 (5), 1299-1311, 2017 | 31 | 2017 |
| ONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways X Ni, X Zhang, CH Hu, T Langridge, RS Tarapore, JE Allen, W Oster, ... Oncotarget 8 (37), 61761, 2017 | 29 | 2017 |
| Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients P Lefrançois, P Xie, L Wang, MT Tetzlaff, L Moreau, AK Watters, ... Oncoimmunology 7 (8), e1467856, 2018 | 26 | 2018 |
| Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA X Ni, HM Richmond, XM Liao, WK Decker, LH Shiue, EJ Shpall, M Duvic Journal of investigative dermatology 128 (11), 2631-2639, 2008 | 25 | 2008 |
| Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease LH Shiue, AM Alousi, C Wei, CM Hosing, M Duvic, X Ni The Journal of investigative dermatology 133 (8), 2098, 2013 | 22 | 2013 |
| Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions SD Doherty, X Ni, CB Doherty, D Jones, X Zhao, LB Owen, M Duvic Archives of dermatological research 298, 353-356, 2007 | 22 | 2007 |
| Dendritic cells and cutaneous T-cell lymphomas. X Ni, M Duvic Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa …, 2011 | 20 | 2011 |
| TruSeq-based gene expression analysis of formalin-fixed paraffin-embedded (FFPE) cutaneous T-cell lymphoma samples: subgroup analysis results and elucidation of biases from … P Lefrançois, MT Tetzlaff, L Moreau, AK Watters, E Netchiporouk, ... Frontiers in Medicine 4, 153, 2017 | 18 | 2017 |
